Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jitendra Wadhane currently holds 262,635 shares of Pyxis Oncology, Inc. (PYXS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jitendra Wadhane has been a net buyer of PYXS stock. They have purchased $17.9K and sold $0 worth of shares.
Jitendra Wadhane's most recent insider trade was on Mar 24, 2026, when they sold 262,635 shares at $0.00 per share.
Jitendra Wadhane serves as Executive at Pyxis Oncology, Inc. (PYXS). They have executed 11 insider transactions totaling $17.9K over their tenure at the company.
Jitendra Wadhane holds the position of Executive at Pyxis Oncology, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 3 years and currently hold a stake valued at $0.
Jitendra Wadhane has shown a buying trading pattern, with $17.9K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Jitendra Wadhane was on Sep 25, 2023, when they purchased $8.8K worth of PYXS shares. This transaction involved 5,000 shares at $1.77 per share.
Jitendra Wadhane currently owns 262,635 shares of Pyxis Oncology, Inc. (PYXS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jitendra Wadhane's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jitendra Wadhane has 11 Form 4 filings on record as an insider at Pyxis Oncology, Inc..
Set alerts for Jitendra Wadhane and 40,000+ other insiders.